Seminars in Nephrology
Volume 27, Issue 5 , Pages 519-523 , September 2007

The (Pro)Renin Receptor: A New Kid in Town

  • Geneviève Nguyen, MD, PhD

      Affiliations

    • Corresponding Author InformationAddress reprint requests to Geneviève Nguyen, MD, PhD, Institut de la Santé et de la Recherche Médicale, INSERM Unit 36, and Collège de France, Experimental Medecine Unit, 11 Place Marcelin Berthelot, 75005, Paris, France.

References 

  1. Carey RM, Siragy HM. Newly recognized components of the renin-angiotensin system: potential roles in cardiovascular and renal regulation. Endocr Rev. 2003;24:261–271
  2. Nguyen G. Renin/prorenin receptors. Kidney Int. 2006;69:1503–1506
  3. Nguyen G. The (pro)renin receptor: pathophysiological roles in cardiovascular and renal pathology. Curr Opin Nephrol Hypertens. 2007;16:129–133
  4. Danser AHJ, Batenburg WW, van Esch JHM. Prorenin and the (pro)renin receptor—an update. Nephrol Dial Transplant. 2007;22:1288–1292
  5. Nguyen G, Delarue F, Burcklé C, et al. Pivotal role of the renin/prorenin receptor in angiotensin II production and cellular responses to renin. J Clin Invest. 2002;109:1417–1427
  6. Luetscher JA, Kraemer FB, Wilson DM, et al. Increased plasma inactive renin in diabetes mellitus a marker of microvascular complications. N Engl J Med. 1985;312:1412–1417
  7. Véniant M, Ménard J, Bruneval P, et al. Vascular damage without hypertension in transgenic rats expressing prorenin exclusively in the liver. J Clin Invest. 1996;98:1966–1970
  8. Methot D, Silversides DW, Reudelhuber TL. In vivo enzymatic assay reveals catalytic activity of the human renin precursor in tissues. Circ Res. 1999;84:1067–1072
  9. Danser AH. Prorenin: back into the arena. Hypertension. 2006;47:824–826
  10. Nabi AH, Kageshima A, Uddin MN, et al. Binding properties of rat prorenin and renin to the recombinant rat renin/prorenin receptor prepared by a baculovirus expression system. Int J Mol Med. 2006;18:483–488
  11. Sielecki AR, Hayakawa K, Fujinaga M, et al. Structure of recombinant human renin, a target for cardiovascular-active drugs, at 2.5 A resolution. Science. 1989;243:1346–1351
  12. Mercure C, Thibault G, Lussier-Cacan S, et al. Molecular analysis of human prorenin prosegment variants in vitro and in vivo. J Biol Chem. 1995;270:16355–16359
  13. Suzuki F, Hayakawa M, Nagakawa T, et al. Human prorenin has “gate and handle” regions for its non-proteolytic activation. J Biol Chem. 2003;278:22217–22222
  14. Ichihara A, Hayashi M, Kaneshiro Y, et al. Inhibition of diabetic nephropathy by a decoy peptide corresponding to the “handle” region for nonproteolytic activation of prorenin. J Clin Invest. 2004;114:1128–1135
  15. Ichihara A, Kaneshiro Y, Takemitsu T, et al. Nonproteolytic activation of prorenin contributes to development of cardiac fibrosis in genetic hypertension. Hypertension. 2006;47:894–900
  16. Ichihara A, Kaneshiro Y, Takemitsu T, et al. Contribution of nonprotelolytically activated prorenin in glomeruli of hypertensive renal damage. J Am Soc Nephrol. 2006;17:2495–2503
  17. Satofuka S, Ichihara A, Nagai N, et al. Suppression of ocular inflammation in endotoxin-induced uveitis by inhibiting non-proteolytic activation of prorenin. Invest Ophthalmol Vis Sci. 2006;47:2686–2692
  18. Ichihara A, Suzuki F, Nakagawa T, et al. Prorenin receptor blockade inhibits development of glomerulosclerosis in diabetic angiotensin II type 1a receptor-deficient mice. J Am Soc Nephrol. 2006;17:1950–1961
  19. Ichihara A, Kaneshiro Y, Suzuki F. Prorenin receptor blockers: effects on cardiovascular complications of diabetes and hypertension. Expert Opin Investig Drugs. 2006;15:1137–1139
  20. Hamming I, Contrepas A, Nguyen G, et al. Regulation of the renal renin/(pro)renin receptor by ACE-inhibition and sodium restriction. J Am Soc Nephrol. 2005;16:120
  21. Schefe JH, Menk M, Reinemund J, et al. A novel signal transduction cascade involving direct physical interaction of the renin/prorenin receptor with the transcription factor promyelocytic zinc finger protein. Circ Res. 2006;99:1355–1366
  22. Luft FC. Renin and its putative receptor remain enigmas. J Am Soc Nephrol. 2007;18:1989–1992
  23. Nguyen G, Delarue F, Berrou J, et al. Specific receptor binding of renin on human mesangial cells in culture increases plasminogen activator inhibitor-1 antigen. Kidney Int. 1996;50:1897–1903
  24. Huang Y, Wongamorntham S, Kasting J, et al. Renin increases mesangial cell transforming growth factor-beta1 and matrix proteins through receptor-mediated, angiotensin II-independent mechanisms. Kidney Int. 2006;69:105–113
  25. Huang Y, Noble N, Zhang J, et al. Renin stimulated TGF-β1 expression is regulated by a mitogen-activated protein kinase in mesangial cells. Kidney Int. 2007;72:45–52
  26. Saris JJ, ‘t Hoen PAC, Garrelds IM, et al. Prorenin induces intracellular signalling in cardiomyocytes independently of angiotensin II. Hypertension. 2006;48:1–8
  27. Burcklé CA, Danser AHJ, Müller DN, et al. Elevated blood pressure and heart rate in human renin receptor transgenic rats. Hypertension. 2006;47:552–556
  28. Kaneshiro Y, Ichihara A, Takemitsu T, et al. Increased expression of cyclooxygenase-2 in the renal cortex of human prorenin receptor gene-transgenic rats. Kidney Int. 2006;70:641–646
  29. Amsterdam A, Nissen RM, Sun Z, et al. Identification of 315 genes essential for early zebrafish development. Proc Natl Acad Sci U S A. 2004;101:12792–12797
  30. Ramser J, Abidi FE, Burckle CA, et al. A unique exonic splice enhancer mutation in a family with X-linked mental retardation and epilepsy points to a novel role of the renin receptor. Hum Mol Genet. 2005;14:1019–1027
  31. L’Huillier N, Sharp MGF, Dunbar DR, Mullins JJ. On the relationship between the renin receptor and the vacuolar proton ATPase membrane sector-associated protein (M8.9). In:  Frohlich ED,  Re RN editor. The Local Cardiac Renin-Angiotensin-Aldosterone System. New York, NY: Springer Science + Business Media; 2006;p. 17–34
  32. Ludwig J, Kerscher S, Brandt U, et al. Identification and characterization of a novel 9.2-kDa membrane sector-associated protein of vacuolar proton-ATPase from chromaffin granules. J Biol Chem. 1998;273:10939–10947
  33. Burckle C, Bader M. Prorenin and its ancient receptor. Hypertension. 2006;48:549–551
  34. Vieira E, Binggeli A, Breu V, Bur D, Fischli W, Guller R, et al. Substituted piperidines—highly potent renin inhibitors due to induced fit adaptation of the active site. Bioorg Med Chem Lett. 1999;9:1397–1402

PII: S0270-9295(07)00091-5

doi: 10.1016/j.semnephrol.2007.07.004

Seminars in Nephrology
Volume 27, Issue 5 , Pages 519-523 , September 2007

Article Tools